Vika Brough, CPA

Vika Brough is the Chief Financial Officer at Mirador Therapeutics with over 20 years in biotechnology and life sciences. She previously served as Senior VP of Finance at Prometheus Biosciences, leading the company’s IPO and subsequent $10.8 billion acquisition by Merck. Vika was also Head of Finance at Human Longevity, Inc., and worked as an auditor at Ernst & Young. She holds a Bachelor of Accounting from San Diego State University and is a Certified Public Accountant (inactive) in California.